tradingkey.logo
tradingkey.logo
Search

KORU Medical Systems Inc

KRMD
Add to Watchlist
3.230USD
+0.010+0.31%
Close 09-18 16:00ET
149.29MMarket Cap
LossP/E TTM

More Details of KORU Medical Systems Inc Company

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

KORU Medical Systems Inc Profile

Ticker SymbolKRMD
Company nameKORU Medical Systems Inc
IPO dateOct 27, 1993
CEOTharby (Linda M)
Number of employees80
Security typeOrdinary Share
Fiscal year-endOct 27
Address100 Corporate Drive
CityMAHWAH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07430
Phone18454692042
Websitehttps://www.korumedical.com/
Ticker SymbolKRMD
IPO dateOct 27, 1993
CEOTharby (Linda M)

Company Executives of KORU Medical Systems Inc

Name
Name/Position
Position
Shareholding
Change
Ms. Linda M. Tharby
Ms. Linda M. Tharby
Director
Director
1.20M
+0.65%
Ms. Linda M. Tharby
Ms. Linda M. Tharby
Director
Director
1.20M
+0.65%
Ms. Linda M. Tharby
Ms. Linda M. Tharby
Director
Director
1.20M
+0.65%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
98.51K
+3.62%
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Linda M. Tharby
Ms. Linda M. Tharby
Director
Director
1.20M
+0.65%
Ms. Linda M. Tharby
Ms. Linda M. Tharby
Director
Director
1.20M
+0.65%
Ms. Linda M. Tharby
Ms. Linda M. Tharby
Director
Director
1.20M
+0.65%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%

FAQs

Who are the top five shareholders of KORU Medical Systems Inc?

The top five shareholders of KORU Medical Systems Inc are: Ms. Linda M. Tharby

How many institutions hold shares of KORU Medical Systems Inc (KRMD)?

As of 2026Q1, 188 institutions hold shares of KORU Medical Systems Inc, with a combined market value of approximately 28.85M, accounting for 62.71% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -129292.00.

What is the biggest source of revenue for KORU Medical Systems Inc?

In 2026Q1, the Domestic Core business generated the highest revenue for KORU Medical Systems Inc, amounting to 7.98M and accounting for 66.25% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.